Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance

医学 内科学 他汀类 胆固醇 动脉粥样硬化性心血管疾病 心脏病学 疾病 炎症
作者
Paul M. Ridker,Lei Lei,Michael J. Louie,Tariq M Haddad,Stephen James Nicholls,Abraham Michael Lincoff,Peter Libby,Steven E. Nissen,on behalf of the CLEAR Outcomes Investigators
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:149 (1): 28-35 被引量:157
标识
DOI:10.1161/circulationaha.123.066213
摘要

BACKGROUND: Among patients treated with statin therapy to guideline-recommended cholesterol levels, residual inflammatory risk assessed by high-sensitivity C-reactive protein (hsCRP) is at least as strong a predictor of future cardiovascular events as is residual risk assessed by low-density lipoprotein cholesterol (LDLC). Whether these relationships are present among statin-intolerant patients with higher LDLC levels is uncertain but has implications for the choice of preventive therapies, including bempedoic acid, an agent that reduces both LDLC and hsCRP. METHODS: The multinational CLEAR-Outcomes trial (Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen Outcomes Trial) randomly allocated 13 970 statin-intolerant patients to 180 mg of oral bempedoic acid daily or matching placebo and followed them for a 4-component composite of incident myocardial infarction, stroke, coronary revascularization, or cardiovascular death, and for all-cause mortality. Quartiles of increasing baseline hsCRP and LDLC were assessed as predictors of future adverse events after adjustment for traditional risk factors and randomized treatment assignment. RESULTS: Compared with placebo, bempedoic acid reduced median hsCRP by 21.6% and mean LDLC levels by 21.1% at 6 months. Baseline hsCRP was significantly associated with the primary composite end point of major cardiovascular events (highest versus lowest hsCRP quartile; hazard ratio [HR], 1.43 [95% CI, 1.24-1.65]), cardiovascular mortality (HR, 2.00 [95% CI, 1.53-2.61]), and all-cause mortality (HR, 2.21 [95% CI, 1.79-2.73]). By contrast, the relationship of baseline LDLC quartile (highest versus lowest) to future events was smaller in magnitude for the primary composite cardiovascular end point (HR, 1.19 [95% CI, 1.04-1.37]) and neutral for cardiovascular mortality (HR, 0.90 [95% CI, 0.70-1.17]) and all-cause mortality (HR, 0.95 [95% CI, 0.78-1.16]). Risks were high for those with elevated hsCRP irrespective of LDLC level. Bempedoic acid demonstrated similar efficacy in reducing cardiovascular events across all levels of hsCRP and LDLC. CONCLUSIONS: Among contemporary statin-intolerant patients, inflammation assessed by hsCRP predicted risk for future cardiovascular events and death more strongly than hyperlipidemia assessed by LDLC. Compared with placebo, bempedoic acid had similar efficacy for reducing cardiovascular risk across hsCRP and LDLC strata. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02993406.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
13333发布了新的文献求助10
刚刚
云非烟完成签到,获得积分10
1秒前
如懿发布了新的文献求助10
3秒前
Chris发布了新的文献求助10
3秒前
潇洒盼柳发布了新的文献求助30
4秒前
4秒前
4秒前
cdercder的应助被郑方舟采纳,获得10
5秒前
希望天下0贩的0的应助被orrange采纳,获得10
5秒前
7秒前
Orange的应助被DAT采纳,获得10
7秒前
7秒前
小春卷完成签到,获得积分10
10秒前
Lucy发布了新的文献求助50
10秒前
10秒前
11秒前
00hello00发布了新的文献求助10
11秒前
11秒前
lele发布了新的文献求助10
12秒前
Super Zzzz发布了新的文献求助10
12秒前
12秒前
小王小王发布了新的文献求助10
12秒前
igiss完成签到,获得积分10
12秒前
13秒前
无极微光的应助被ku采纳,获得20
13秒前
渡颀发布了新的文献求助10
13秒前
脑洞疼的应助被Layman采纳,获得10
13秒前
小蘑菇的应助被狂野的访旋采纳,获得10
14秒前
molihuakai的应助被涵霸天采纳,获得10
14秒前
zsy发布了新的文献求助10
15秒前
15秒前
科研通AI65的应助被灝男采纳,获得10
16秒前
rio发布了新的文献求助10
16秒前
16秒前
Super Zzzz完成签到,获得积分10
18秒前
COA-ACP完成签到,获得积分10
19秒前
糊涂神发布了新的文献求助10
19秒前
蓝天发布了新的文献求助10
19秒前
毛毛完成签到,获得积分10
20秒前
13333完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177802
求助须知:如何正确求助?哪些是违规求助? 9568632
关于积分的说明 21799933
捐赠科研通 7772424
什么是DOI,文献DOI怎么找? 3432505
关于科研通互助平台的介绍 2556698
邀请新用户注册赠送积分活动 2478055